This metabolite features a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 approximately fifty% in the mother or father drug. Plasma concentrations of the metabolite are somewhere around forty% of Individuals found for sildenafil, so which the metabolite accounts for about 20% of sildenafil's pharmacologic consequences